Bay Street News, March, 2024

WATERTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing […]

Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL […]

– Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and […]

Fourth quarter adjusted operating income and adjusted diluted EPS at the high-end of guidance Generated nearly $590 million in operating […]

BOCA RATON, Fla., March 06, 2024 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced the […]

BOSTON, March 06, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively […]

– Full Year 2023 Revenues and Share of NPI Revenues Interest total $254.6 million –– Full Year 2023 Net Loss […]

PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a […]

    OMEGA FLEX, INC. (OFLX)     For the Period Ended December 31,     Twelve Months   Three […]

HOUSTON, March 06, 2024 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced its operating and […]